# Influenza Vaccine Trial in HIV Uninfected Pregnant Women

> **NCT01306669** · PHASE3 · COMPLETED · sponsor: **University of Witwatersrand, South Africa** · enrollment: 2116 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent influenza vaccine
- **BIOLOGICAL:** Normal saline

## Key facts

- **NCT ID:** NCT01306669
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 2116 (ACTUAL)
- **Last updated:** 2018-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306669, "Influenza Vaccine Trial in HIV Uninfected Pregnant Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01306669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*